By Dennis Thompson HealthDay ReporterWEDNESDAY, Dec. 17, 2025 (HealthDay News) — An over-the-counter supplement called lipoic ...
The approval marks the first new stroke treatment authorized in nearly 27 years, offering an additional option for managing ...
Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...
The AAN’s first-ever functional seizure guideline targets stigma and unnecessary treatment, offering clearer diagnostic steps ...
Depression has been tied to a two-fold increased risk offor epilepsy and a suboptimal response to initial therapy, ...
DOC Medical Center opens its advanced Neurosciences division, offering cutting-edge neuro and spine care in Qatar.
Treatment with Kisunla was associated with sustained clinical benefits, specifically less symptom worsening and significant ...
People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids, new treatment ...
Tolebrutinib failed to meet the primary endpoint in the phase 3 PERSEUS study involving patients with primary progressive multiple sclerosis.
Psychological interventions may be effective for achieving freedom from functional seizures, according to new practice ...
We used to assume bird flu was a risk solely for outdoor hunters, but new data suggests the virus is entering the home ...
In pediatric-onset multiple sclerosis, switching to oral or infusion therapies was linked to fewer relapses than switching between injectable treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback